Photo from Hope Rugo/X
Jun 2, 2024, 23:39
Hope Rugo: Fabrice Andre presents DB07 at ASCO24
Hope Rugo, Medical hematologist-oncologist at UCSF, shared on X/Twitter:
“Fabrice Andre presents DB07. The expected amazing and durable response to first line TDXd +/- Pertuzumab. Adding P almost tripled grade 3 diarrhea rates; no grade 5 ILD. Imp implications for DB09 and great to see this efficacy.”
Source: Hope Rugo/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14